The prevalence of mitragynine (kratom) in forensic toxicology casework has steadily increased over time. Readily available and currently legal, mitragynine is widely used for its stimulant and, depending on concentration, sedative effects. Our laboratory analyzed various fluid and tissue specimens from 51 postmortem cases to investigate the distribution of mitragynine and its active metabolite 7-hydroxymitragynine. Central and peripheral blood concentrations were compared, with an average heart blood to femoral blood ratio being 1.37 for mitragynine and 1.08 for 7-hydroxymitragynine. This ratio >1.0 suggests that mitragynine has some propensity toward postmortem redistribution; however, the difference in concentrations of mitragynine and 7-hydroxymitragynine is not statistically significant. Large average mitragynine to 7-hydroxymitragynine ratios of 30.9 in femoral blood and 32.4 in heart blood were observed compared to average ratios of 14.8 in vitreous humor and 16.9 in urine. In addition, the stability of these two compounds was investigated in both matrix and organic solvent. When stored refrigerated (4°C), mitragynine was stable for up to 30 days and 7-hydroxymitragynine was stable for up to 7 days with an analyte loss of <20%. Following 60 days of refrigerated storage, 7-hydroxymitragynine concentrations dropped over 50% from initial concentrations. Methanolic preparations of mitragynine and 7-hydroxymitragynine were stable following 3 months of storage at -20°C.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jat/bkae099 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Postmortem distribution of mitragynine and 7-hydroxymitragynine in 51 cases.
J Anal Toxicol
December 2024
Tarrant County Medical Examiner's Office, Fort Worth, TX 76104, United States.
The prevalence of mitragynine (kratom) in forensic toxicology casework has steadily increased over time. Readily available and currently legal, mitragynine is widely used for its stimulant and, depending on concentration, sedative effects. Our laboratory analyzed various fluid and tissue specimens from 51 postmortem cases to investigate the distribution of mitragynine and its active metabolite 7-hydroxymitragynine.
View Article and Find Full Text PDFThe neuropharmacology of kratom, a novel psychoactive natural product.
Prog Neuropsychopharmacol Biol Psychiatry
December 2024
College of Pharmacy, Department of Pharmaceutical Sciences, Midwestern University, Glendale, AZ, United States; College of Pharmacy, Department of Medicinal Chemistry, University of Florida, Gainesville, FL, United States. Electronic address:
Kratom (Mitragyna speciosa, Korth.) is a tropical tree that is indigenous to Southeast Asia. When ingested, kratom leaves or decoctions from the leaves have been reported to produce complex stimulant and opioid-like effects.
View Article and Find Full Text PDFKratom Consumption - The Tales of Three Patients.
J Psychoactive Drugs
November 2024
Psychiatry Department, Dartmouth's Geisel School of Medicine, Hanover, NH, USA.
The rising prevalence of kratom use in the United States has led to increased encounters with individuals who consume kratom and those who develop Kratom Use Disorder (KUD) among healthcare professionals. This case series highlights the need for diverse treatment approaches tailored to the individual motivations for kratom consumption. Three cases are presented: one involving the progression from kratom use for energy to opioid-driven use with subsequent challenges in detoxification and transition to naltrexone necessitating buprenorphine low-dose induction for maintenance; another detailing successful inpatient detoxification using methadone and symptom-driven clonidine, followed by successful maintenance treatment with naltrexone; and a final case involving kratom consumption for pain and anxiety self-management by an individual without a history of addictive disorders, without meeting KUD criteria.
View Article and Find Full Text PDFElectrical breakdown in liquid-phase processing on an enhancement of 7-hydroxymitragynine conversion from mitragynine in (Kratom).
Heliyon
September 2024
Thailand Institute of Nuclear Technology (Public Organization), Ongkharak, Nakhon Nayok, 26120, Thailand.
This study investigates the impact of the Electrical Breakdown in Liquid-phase (EBL) process on alkaloid transformation in (Kratom) leaves, focusing on the conversion of mitragynine (MG) to 7-hydroxy mitragynine (7-OH-MG) by using advanced oxidation processes (AOPs). A novel reactor has been developed to enhance plasma exposure to Kratom leaf powdered solutions during the EBL process. Two distinct electrical voltage characteristics, half-positive and negative half-waves, have been utilized for the EBL, with an output voltage of 4.
View Article and Find Full Text PDFRed kratom and red corvette: A case of mania induced by kratom withdrawal.
Int J Psychiatry Med
September 2024
Department of Psychiatry, Nassau University Medical Center, East Meadow, NY, USA.
Article Synopsis
- Kratom is a plant from Southeast Asia that some people in the U.S. use to help with pain and getting off stronger drugs like opioids.
- A 56-year-old man, who had stopped using Kratom suddenly, became very agitated and aggressive, leading him to the hospital.
- Doctors found out that his crazy behavior was caused by Kratom withdrawal, which is a rare but serious condition that hasn't been reported like this before.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!